Calendar Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq Other stock markets 01:30:00 17/07/2024 am IST			5-day change	1st Jan Change
2.19 ^USD	-0.45%		+19.57%	+94.69%

08/05	Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06/05	Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC	CI

Chart calendar Context Therapeutics Inc.

1db782bbd6c390762adb72997f.OUbK1KK4E-nOuRQ-NlvjFW5EqCR34IQ3XvVlcZEj2Vk.QwWbmsnaKoK_73ZLBRGnXVwKwHMHjNYGCbcdC-l7ihV6LPOCltMmo53wWQ~b490eff8425c0a4a89b54060c81b3b02

Upcoming events on Context Therapeutics Inc.

08/08/2024	Q2 2024 Earnings Release (Projected)
07/11/2024	Q3 2024 Earnings Release (Projected)
19/03/2025	Q4 2024 Earnings Release (Projected)
07/05/2025	Q1 2025 Earnings Release (Projected)

Past events on Context Therapeutics Inc.

13/06/2024 06:00 pm	Annual General Meeting
09/05/2024 01:36 am	Q1 2024 Earnings Release
08/04/2024 11:45 pm	Needham Healthcare Conference
21/03/2024 05:13 pm	Q4 2023 Earnings Release
10/11/2023 02:45 am	Q3 2023 Earnings Release
03/11/2023 09:30 pm	Society for Immunotherapy of Cancer Meeting - Abstract Number : 1183
17/08/2023 09:00 pm	H.C. Wainwright Immune Cell Engager Conference - Fireside Chat
10/08/2023 01:40 am	Q2 2023 Earnings Release
07/08/2023 08:00 pm	BTIG Biotechnology Conference - Fireside Chat
31/05/2023 06:00 pm	Annual General Meeting
11/05/2023 02:09 am	Q1 2023 Earnings Release
19/04/2023 06:15 pm	Needham Healthcare Conference
17/04/2023 06:30 pm	American Association for Cancer Research Meeting - Abstract Number: 1865 / 4
05/04/2023 07:10 pm	Diamond Equity Research Research Emerging Growth Invitational Conference
23/03/2023 02:38 am	Q4 2022 Earnings Release
08/12/2022 04:30 am	San Antonio Breast Cancer Symposium - Abstract: 1300819
08/12/2022 04:30 am	San Antonio Breast Cancer Symposium - Abstract: 1307318
01/12/2022 09:30 pm	R&D Day
10/11/2022 02:44 am	Q3 2022 Earnings Release
26/10/2022 07:00 pm	ThinkEquity Conference

Upcoming sector events for Context Therapeutics Inc.

22/07/2024	MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release
22/07/2024 04:30 pm	IQVIA HOLDINGS INC.: Q2 2024 Earnings Release
24/07/2024	SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release
24/07/2024	ALKERMES PLC: Q2 2024 Earnings Release (Projected)
24/07/2024	ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release
25/07/2024	LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 10:30 am	BACHEM HOLDING AG: Q2 2024 Earnings Release
26/07/2024	PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 10:30 am	BB BIOTECH AG: Q2 2024 Earnings Release
29/07/2024	CRISPR THERAPEUTICS AG: Q2 2024 Earnings Release (Projected)

More events

Past sector events for Context Therapeutics Inc.

15/07/2024 11:15 am	ADDLIFE AB: Q2 2024 Earnings Release
10/07/2024 12:31 pm	SUNMAX BIOTECHNOLOGY CO., LTD.: June 2024 Sales and Revenue Release
10/07/2024 11:21 am	POLARIS GROUP: June 2024 Sales and Revenue Release
11/06/2024 12:34 pm	SUNMAX BIOTECHNOLOGY CO., LTD.: May 2024 Sales and Revenue Release
07/06/2024 12:27 pm	POLARIS GROUP: May 2024 Sales and Revenue Release
30/05/2024 01:31 am	IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 04:30 pm	CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 10:30 am	EVOTEC SE: Q1 2024 Earnings Release
22/05/2024 02:44 am	ALVOTECH: Q1 2024 Earnings Release
21/05/2024 04:30 pm	EXSCIENTIA PLC: Q1 2024 Earnings Release